SerenaPKoenigMD
Infectious Disease • Boston, MAAssociate Professor of Medicine, Brigham and Women's Hospital, Harvard Medical School
Dr. Koenig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Division of Global Health Equity, Brigham and Women's Hospital
75 Francis Street
Boston, MA 02115Phone+1 617-732-6660
Education & Training
Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2003 - 2006
Brigham and Women's HospitalResidency, Internal Medicine, 1995 - 1998
University of Washington School of MedicineClass of 1995
Certifications & Licensure
MA State Medical License 1997 - 2026- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Same-Day HIV Testing and Treatment Initiation to Improve Retention in Care Start of enrollment: 2013 Aug 01
- A Trial of Same-Day Testing and Treatment to Improve Outcomes Among Symptomatic Patients Newly Diagnosed With HIV Start of enrollment: 2017 Nov 06
- Immediate Fast-Track Versus Standard Care for Persons Living With HIV in Haiti Start of enrollment: 2018 Nov 27
- Join now to see all
Publications & Presentations
PubMed
- Potential Utility of C-reactive Protein for Tuberculosis Risk Stratification Among Patients With Non-Meningitic Symptoms at HIV Diagnosis in Low- and Middle-income Cou...Kathryn Dupnik, Vanessa R Rivera, Nancy Dorvil, Yanique Duffus, Hanane Akbarnejad
Open Forum Infectious Diseases. 2024-07-01 - Successful outcomes for patients with drug-resistant tuberculosis despite civil unrest and COVID-19 in Haiti.Stalz Charles Vilbrun, Ariadne Souroutzidis, Kathleen F Walsh, Joshua Ellis, Colette Guiteau
PLOS Global Public Health. 2023-01-01 - Time to Culture Conversion of Bedaquiline and High-Dose Isoniazid for Drug-Resistant Tuberculosis.Kathleen F Walsh, Stalz Charles Vilbrun, Ariadne Souroutzidis, Joshua Ellis, Sobiesyke Delva
Open Forum Infectious Diseases. 2022-09-01
Press Mentions
Interesting and Important Studies from IAS 2021 and IDWeek That Caught My EyeOctober 31st, 2021
Update in Tuberculosis/Pulmonary Infections 2015April 19th, 2016
Grant Support
- Cost-Effectiveness Of Early Vs. Delayed Antiretroviral Therapy In HaitiFogarty International Center2009–2011
- Health Outcomes/Cost Of Early VS Delayed ART In HaitiFogarty International Center2004–2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
